(Q36789988)

16 August 2017

title

Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review (English)

1 reference

16 August 2017

1 reference

2

Michael Benatar

1 reference

16 August 2017

M Scott Perry

1

1 reference

16 August 2017

publication date

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

48

1 reference

16 August 2017

issue

6

1 reference

16 August 2017

page(s)

1123-1127

1 reference

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01003.X

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01003.X

Efficacy and safety of topiramate in infants according to epilepsy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01003.X

Effectiveness of first antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01003.X

Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01003.X

Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01003.X

Discontinuation of levetiracetam because of behavioral side effects: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.01003.X

10.1111/J.1528-1167.2007.01003.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference